Clinical Trials Browser

Phase 2 × Neoplasms × Radiosurgery × Clear all

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT05655715 2024-10-16

CheckPRO

Phase 2 Completed

90 enrolled

Genitourinary

Neoplasms, Prostatic Neoplasms

NCT02904954 2023-10-11

Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage I, II and IIIA Non-small Cell Lung Cancer

Phase 2 Completed

60 enrolled 12 charts

Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT01622621 2020-09-11

Stereotactic Body Radiotherapy (SBRT) Versus Sublobar Resection for High-Risk Patients Non-Small Lung Cancer

Phase 2 Terminated

20 enrolled

Thoracic

Lung Neoplasms, Neoplasms

NCT04130399 2019-10-17

Study of Neoadjuvent Chemotherapy Followed by SBRT in Patients With Resectable and Borderline Resectable Pancreatic Cancer

Phase 2 Withdrawn

Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT03029416 2018-10-15

Two Radiation Dose Schedules of SBRT to Lung Metastases < 5cm in Dimension

Phase 2 Withdrawn

Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT00587964 2016-02-22

Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases

Phase 2 Completed

51 enrolled 6 charts

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Sarcoma, Testicular Neoplasms

NCT00983541 2015-08-19

Chemoradiation +Gemcitabine +Continuous 5-FU (Fluorouracil) Followed by High Dose Brachytherapy/Stereotactic Radiation Boost in Locally Advanced Intra/Extrahepatic Cholangiocarcinoma

Phase 2 Terminated

1 enrolled 4 charts

Gastrointestinal

Liver Neoplasms, Neoplasms, Cholangiocarcinoma

NCT01754623 2015-08-13

GTX-RT in Borderline Resectable Pancreatic Cancer

Phase 2 Terminated

9 enrolled 7 charts

Gastrointestinal

Neoplasms, Pancreatic Neoplasms

Clinical Trials

Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC

CheckPRO

Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage I, II and IIIA Non-small Cell Lung Cancer

Stereotactic Body Radiotherapy (SBRT) Versus Sublobar Resection for High-Risk Patients Non-Small Lung Cancer

Study of Neoadjuvent Chemotherapy Followed by SBRT in Patients With Resectable and Borderline Resectable Pancreatic Cancer

Two Radiation Dose Schedules of SBRT to Lung Metastases < 5cm in Dimension

Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases

Chemoradiation +Gemcitabine +Continuous 5-FU (Fluorouracil) Followed by High Dose Brachytherapy/Stereotactic Radiation Boost in Locally Advanced Intra/Extrahepatic Cholangiocarcinoma

GTX-RT in Borderline Resectable Pancreatic Cancer